Norland acquires ultrasound technology
Bone densitometry vendor Norland Medical Systems of White Plains,NY, has acquired rights to an ultrasound-based bone measurementsystem through an agreement with Vitel, a Texas company affiliatedwith the University of Texas Southwestern Medical Center in
Bone densitometry vendor Norland Medical Systems of White Plains,NY, has acquired rights to an ultrasound-based bone measurementsystem through an agreement with Vitel, a Texas company affiliatedwith the University of Texas Southwestern Medical Center in Dallas.
Vitel is developing bone measurement devices using a technologyit has licensed from the university called ultrasound criticalangle reflection (UCR). UCR technology can provide a quantitativeassessment of bone quality, according to Norland, making possiblean independent assessment of both cortical and trabecular bone.
Norland acquired exclusive worldwide rights to all productsdeveloped by Vitel and has agreed to make an equity investmentin Vitel. An ultrasound-based bone densitometry system would complementx-ray-based systems marketed by Norland and its Dove Medical Systemssubsidiary (SCAN 4/10/96).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Samsung Debuts New Ultrasound Modality Geared Toward Women's Health and Urology
November 15th 2023Combining enhanced imaging capabilities, workflow efficiencies and artificial intelligence (AI)-enabled technology to improve the diagnosis and management of health conditions in women, Samsung has launched the V6 ultrasound system.
Study Links PTSD to Higher Carotid Atherosclerosis and White Matter Hyperintensity in Midlife Women
November 6th 2023Ultrasound and MRI findings from a new study suggest that greater carotid atherosclerosis and elevated white matter hyperintensities among women with the APOEe4 genotype, a strong risk factor for Alzheimer’s disease, are associated with increased PTSD symptoms in midlife women.
